Unternehmen Albany Molecular Research, Inc. Deutsche Boerse AG
Aktien
AYM
US0124231095
AYM
Biotechnologie
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Philip W Macnabb
CEO | Chief Executive Officer | - | 01.05.23 |
Meera Khullar
CMP | Compliance Officer | - | 01.03.19 |
Prakash Pandian
CTO | Chief Tech/Sci/R&D Officer | - | 01.06.18 |
Chief Tech/Sci/R&D Officer | - | 01.10.19 | |
Javier Gallo
PRN | Corporate Officer/Principal | - | - |
Scott Wagner
PRN | Corporate Officer/Principal | - | 01.01.19 |
Human Resources Officer | - | 01.10.17 | |
Stacie Phillips
LAW | General Counsel | 50 | 01.08.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | - |
Sean Cunningham
BRD | Director/Board Member | 48 | - |
William McMullan
BRD | Director/Board Member | 46 | - |
Maria Hilado
BRD | Director/Board Member | 59 | 01.09.21 |
Director/Board Member | 46 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 48 631 283 | 30 278 873 ( 62,26 %) | 5 512 000 ( 11,33 %) | 62,26 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+34,01 % | 52,85 Mrd. | |
-8,02 % | 38,87 Mrd. | |
+34,86 % | 38,24 Mrd. | |
-11,12 % | 26,79 Mrd. | |
+12,56 % | 26,16 Mrd. | |
-19,62 % | 19,9 Mrd. | |
+39,18 % | 13,18 Mrd. | |
+31,47 % | 12,24 Mrd. | |
-3,40 % | 11,79 Mrd. |